Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Lee, Chung-Han; Motzer, Robert; Hoetker, Andreas et al.
Novel chromosome copy number changes to predict clinical response to sunitinib in patients with advanced renal cell carcinoma.JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015
Osterborg, Anders; Wierda, William G.; Mayer, Jiri et al.
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsBRITISH JOURNAL OF HAEMATOLOGY. Bd. 170. H. 1. 2015 S. 40-49
Mehnert, Anja; Braehler, Elmar; Faller, Hermann et al.
One in Three Patients With Cancer Meets the Criteria for Mental Disorders: What Does That Mean? ReplyJOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 25. 2015
Vogel, Arndt; Kasper, Stefan; Weichert, Wilko et al.
Panitumumab in combination with gemcitabine/cisplatin (GemCis) for patients with advanced kRAS WT biliary tract cancer: A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015
Doersam, B.; Nagel, G.; Kraus, A. et al.
PARP-1 deficiency protects against colitis-associated colorectal cancerNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 388. 2015 S. S74-S74
Kloos, Bianca; Chakraborty, Sushmita; Lindner, Sonja G. et al.
Pasteurella multocida toxin-induced osteoclastogenesis requires mTOR activationCELL COMMUNICATION AND SIGNALING. Bd. 13. 2015
Kreipe, H; Schmidt, M
Pathologie, Prognose und PrädiktionUntch, Harbeck, Thomssen, Costa (Hrsg). Colloquium Senologie 2015/2016. München: Agileum Verlagsgesellschaft mbH 2015
Jaeger, Wolfgang; Xue, Hui; Hayashi, Tetsutaro et al.
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapiesONCOTARGET. Bd. 6. H. 25. 2015 S. 21522-21532
Briest, S.; Papsdorf, K.; Koehler, U. et al.
Patients with early stage breast cancer. Less mentally distressed than patients with advanced stages?ONKOLOGE. Bd. 21. H. 3. 2015 S. 245-249
Trautmann, F.; Singer, S.; Schmitt, J.
Patients with soft tissue sarcoma comprise a higher frequency of comorbidities than cancer-free individuals - a secondary data analysisOncology Research and Treatment. Bd. 38. 2015 S. 248-248